HLA PRE-TRANSPLANT WORKUP SENSITIZED RECIPIENT PANEL 5 Test
Test Name: HLA PRE-TRANSPLANT WORKUP SENSITIZED RECIPIENT PANEL 5 Test
Components:
- Recipient: HLA DNA Typing for Kidney / Liver transplant, PCR Low resolution Luminex
- HLA T & B cell lymphocyte flow cytometry cross match vs potential donor
- Single antigen bead (SAB) IgG Class I & II Luminex
Price: 7800.0 AED
Sample Condition:
- RECIPIENT: 9 mL (6 mL min.) serum from 3 SST’s AND 4 mL (2 mL min.) whole blood in 1 Lavender top (EDTA) tube AND 4 mL (2 mL min.) whole blood in 1 Green Top (Sodium Heparin) tube.
- Collect specimen preferably 48 hours after dialysis.
- Ship at 18-22°C. DO NOT REFRIGERATE OR FREEZE.
- Doctor’s prescription on the letterhead with 1 photograph each of recipient and donor duly stamped AND Consent form for HLA Typing for Solid organ transplant (Form 33) is mandatory.
Report Delivery: 10-12 days
Method: Reverse SSOP – Luminex, Luminex X-Map technology, Flow cytometry
Test Type: Transplantation
Doctor: Nephrologist
Test Department:
Pre Test Information: Collect specimen preferably 48 hours after dialysis. Doctor’s prescription on the letterhead with 1 photograph each of recipient and donor duly stamped AND Consent form for HLA Typing for Solid organ transplant (Form 33) is mandatory.
Test Details:
The Sensitized Recipient Panel 5 (SRP5) test is a laboratory test that is used to determine the level of sensitization of a potential organ transplant recipient. The test is typically performed prior to a transplant to assess the risk of rejection and to determine the compatibility of the donor organ.
The SRP5 test specifically measures the level of antibodies in the recipient’s blood against five common human leukocyte antigen (HLA) types. HLA are proteins found on the surface of cells that play a critical role in the immune system’s recognition of self and non-self cells. The higher the level of antibodies against a particular HLA type, the more likely the recipient is to reject an organ from a donor with that HLA type.
The SRP5 test is typically performed using a blood sample from the recipient. The sample is then analyzed in a laboratory to measure the level of antibodies against each of the five HLA types. The results of the test are used to determine the likelihood of a successful transplant and to guide the selection of a compatible donor organ.
In general, a lower level of antibodies against the five HLA types tested in the SRP5 test is associated with a lower risk of rejection and a higher likelihood of a successful transplant. However, each case is unique, and other factors, such as the overall health of the recipient and the quality of the donor organ, must also be considered in determining the best course of treatment.
| Test Name | HLA PRE-TRANSPLANT WORKUP SENSITIZED RECIPIENT PANEL 5 Test |
|---|---|
| Components | Recipient : *HLA DNA Typing for Kidney / Liver transplant, PCR Low resolution Luminex*HLA T & B cell lymphocyte flow cytometry cross match vs potential donor*Single antigen bead (SAB) IgG Class I & II Luminex |
| Price | 7800.0 AED |
| Sample Condition | RECIPIENT: 9 mL (6 mL min.) serum from 3 SST’s AND 4 mL ( 2 mL min.) whole blood in 1 Lavender top (EDTA) tube AND4 mL (2 mL min.) whole blood in 1 Green Top (Sodium Heparin) tube. Collect specimen preferably 48 hours after dialysis. Ship at 18\u0192??22?\u00f8C. DO NOT REFRIGERATE OR FREEZE. Doctor’s prescription on the letter head with 1 photograph each of recipient and donor duly stamped AND Consent form for HLA Typing for Solid organ transplant (Form 33) is mandatory. |
| Report Delivery | 10-12 days |
| Method | Reverse SSOP – Luminex, Luminex X-Map technology, Flow cytometry |
| Test type | Transplantation |
| Doctor | Nephrologist |
| Test Department: | |
| Pre Test Information | Collect specimen preferably 48 hours after dialysis. Doctor’s prescription on the letter head with 1 photograph each of recipient and donor duly stamped AND Consent form for HLA Typing for Solid organ transplant (Form 33) is mandatory. |
| Test Details |
The Sensitized Recipient Panel 5 (SRP5) test is a laboratory test that is used to determine the level of sensitization of a potential organ transplant recipient. The test is typically performed prior to a transplant to assess the risk of rejection and to determine the compatibility of the donor organ. The SRP5 test specifically measures the level of antibodies in the recipient’s blood against five common human leukocyte antigen (HLA) types. HLA are proteins found on the surface of cells that play a critical role in the immune system’s recognition of self and non-self cells. The higher the level of antibodies against a particular HLA type, the more likely the recipient is to reject an organ from a donor with that HLA type. The SRP5 test is typically performed using a blood sample from the recipient. The sample is then analyzed in a laboratory to measure the level of antibodies against each of the five HLA types. The results of the test are used to determine the likelihood of a successful transplant and to guide the selection of a compatible donor organ. In general, a lower level of antibodies against the five HLA types tested in the SRP5 test is associated with a lower risk of rejection and a higher likelihood of a successful transplant. However, each case is unique, and other factors, such as the overall health of the recipient and the quality of the donor organ, must also be considered in determining the best course of treatment. |
